SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Techperson who wrote (173)5/8/1997 5:02:00 PM
From: Techperson   of 998
 
"We don't take the position that Myotrophin doesn't work, but we don't take the position that it works, either," said FDA reviewer John Feeney. "We just think there's not enough evidence. For that reason we think it would be hard to approve."
OTOH
Still another agency official, Dr. Robert Temple, said the FDA brought the issue to the panel because there is some disagreement within the agency about the drug's benefits. And Dr. Robert Miller, chairman of the California Pacific Medical Center's neurology department, said; "I find this clinical study very convincing." (Note - I think he was testifying and is not a member of the panel, but I'm not sure yet.)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News